Reflux nephropathy: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 12: Line 12:
   MeshID        = |
   MeshID        = |
}}
}}
{{SI}}
{{Reflux nephropathy}}


'''For patient information on this page, click [[Reflux nephropathy (patient information)|here]]'''
'''For patient information on this page, click [[Reflux nephropathy (patient information)|here]]'''

Revision as of 14:11, 27 September 2012

Reflux nephropathy
ICD-9 593.73
DiseasesDB 11209
MedlinePlus 000459

Reflux nephropathy Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Reflux nephropathy from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Reflux nephropathy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Reflux nephropathy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Reflux nephropathy

CDC on Reflux nephropathy

Reflux nephropathy in the news

Blogs on Reflux nephropathy

Directions to Hospitals Treating Reflux nephropathy

Risk calculators and risk factors for Reflux nephropathy

For patient information on this page, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]

Overview

Reflux nephropathy, RN is a term applied when small and scarred kidneys (chronic pyelonephritis, CPN) are associated with vesico-ureteric reflux (VUR). CPN being the commonest cause, there are other causes including analgesic nephropathy and obstructive injury. Scarring is essential in developing RN and occurs almost during the first five years of life. The end results of RN are hypertension, proteinuria, CRF and eventually ESRD, end stage renal disease.

Epidemiology and Demographics

There is a genetic predisposition, first-degree relatives have a great increase in the chance of VUR.

The gene frequency is estimated to be 1:600. All children with UTI should be investigated for VUR.

Diagnosis

It is diagnosed by micturating cystography, scarring can of course be demonstrated by ultrasound or DMSA.

Treatment

The aim of treatment is to reduce renal scarring. Those children with grade II or worse should receive low dose prophylactic antibiotics (Nitrofurantoin, trimethoprim, co-trimoxazole, cefalexin in those with CRF). Hypertension should be managed with ACE inhibitors or ARB's. Other treatment modalities also include surgery (endoscopic injection of collagen behind the intra-vesical ureter, ureteric re-implantation or lengthening of the submucosal ureteric tunnel) which has its protagonists.

References

Template:Nephrology


Template:WikiDoc Sources